Liang Mao is currently Executive Director at WuXi STA, a subsidiary of WuXi AppTec. Prior to WuXi STA, Liang worked at Novartis in the pre-formulation team supporting compound developability assessment, physical form screening and selection, and preclinical formulation development. Prior to Novartis, Laing held roles in both a research institution and a biopharmaceutical company, supporting early drug development. He has expertise in drug developability assessment, physical form screening, and bioavailability enhancement technologies. Liang holds a master’s degree in bio-chemical engineering from Nanjing University of Technology.